AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Zensights Names Barry Brandstetter as Principal

May 7, 2019

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--May 7, 2019--Zensights® is pleased to announce that Barry Brandstetter has joined the organization as Principal. In his role, Mr. Brandstetter will work closely with Zensights pharmaceutical company clients to identify, contract with, and develop durable and healthy partnerships with commercial and clinical services providers. His focus will include: 1) optimal vendor selection to ensure mutually beneficial client-vendor engagements; 2) wise budgetary spending to optimize clients’ financial resources; 3) carefully crafted contracts to safeguard clients’ organizations; and 4) ongoing consulting with, and mentoring, of clients to build productive client-vendor relationships and positive business results.

Mr. Brandstetter is an experienced commercial leader and proven business builder who brings over 30 years of pharmaceutical manufacturer and service provider know-how to Zensights’ clients. He has built a broad base of knowledge and experience in pharmaceutical organizations, as well as in a top-10 global pharma ad agency and a leading digital marketing agency. His combination of client-side and service provider experience enables him to identify opportunities, as well as develop solutions and recommendations to meet clients’ business needs.

Most recently, Mr. Brandstetter was Global Head of Commercial Integration for Syneos Health. In this role, he and his team worked with pharmaceutical companies to provide fully integrated commercial infrastructure, strategy, and support services to launch and grow new products. Previously, Mr. Brandstetter gained significant client-side experience at Roche, Abbott, GSK, and Sanofi. His roles included General Manager, Head of HR and Sales Operations & Training, Marketing Director, Regional Sales Manager, Product Manager, and Marketing Research Manager. In addition, Mr. Brandstetter was Senior Executive VP of GSW Worldwide, where he managed the Client Service, PR, and HR functions. He also served as Senior VP of Client Service for Possible Worldwide, a leading digital marketing agency for CPG, technology, and healthcare companies. Over the course of his career, Mr. Brandstetter developed strong skills in managing and leading teams, brand management, financial management, business development, and contract negotiation.

Bob Jansen, CEO of Zensights, stated, “With his pharma company and service provider background, Barry brings a breadth and depth of experience that is incredibly valuable to our clients. He is a business builder, problem solver, and natural collaborator, and is one of those people with whom his colleagues and clients genuinely like to partner. Barry complements our existing executive leadership team and will be instrumental in driving value for both our firm and for our clients’ businesses. We are thrilled to have Barry join Zensights.”

About Zensights

Zensights is a pharmaceutical vendor management company focused on making the complex world of vendor selection easier for the BioPharma manufacturer. Zensights’ signature software tool Linx™ analyzes, aggregates, and provides an overall market assessment of the capabilities of third-party vendors that service the bio-tech, pharmaceutical, and life sciences industries. The proprietary tool is populated with key decision maker and budget holder feedback to easily and strategically orchestrate RFPs and RFIs from the highest-rated vendors servicing the BioPharma Industry.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190507005627/en/

CONTACT: Duane Morris LLP

Amy Abbonizio, 215-979-7376

alabbonizio@duanemorris.com

KEYWORD: UNITED STATES NORTH AMERICA ARIZONA

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL RESEARCH SCIENCE

SOURCE: Zensights

Copyright Business Wire 2019.

PUB: 05/07/2019 12:00 PM/DISC: 05/07/2019 12:00 PM

http://www.businesswire.com/news/home/20190507005627/en